https://www.instagram.com/uitmpalam3/

Uitm.Palam33, Kuala (2025)

10/07/2021

As we know, covid-19 is now widespread in Malaysia. The rate of covid 19 infection in Malaysia is very worrying. With this we from Uitm Puncak Alam are preparing a few initiatives to encourage Malaysians to participate to save our country. This vaccine also cannot prevent you from the virus itself. This vaccine can only save you from death or can reduce pain if exposed to this virus. Accept a little of our small initiative for you, our country, Malaysia.

10/07/2021

Vaccine Distribution Strategy and Target Group

👮🏻‍♂️ 👨🏼‍⚕️ The first strategy is to vaccinate frontliners, especially those in the health sector, to ensure that they are protected from contracting COVID-19. This is to ensure that the health sector continues to operate optimally.

👵🏼👴🏼 The second strategy is to reduce the burden of disease for those in high-
risk groups so they are protected from
a COVID-19 infections. This in turn can reduce the load on the Malaysian public health system.

📈🏘 The third strategy to control this pandemic is for the vaccination to be carried out in high-risk areas throughout phases two and three through risk assessment to control the spread of the disease.

10/07/2021

DRIVE THRU COVID-19 VACCINATION

The drive-through option for Covid-19 vaccination is currently only open to those getting their second jab. Besides that, a total of 13,500 persons with disabilities in klang valley will receive covid-19 vaccines at the country’s first drive through vaccination centre.
The increase in the number of daily vaccination was also supported by 276 vaccination centres (PPV) nationwide, along with an increase in drive-thru PPVs. Deputy Health Minister Datuk Dr Noor Azmi Ghazali reportedly said that more drive-thru PPVs will be established nationwide. Currently, the drive-thru PPVs are located at the Universiti Sains Malaysia Hospital and Universiti Kebangsaan Malaysia Specialist Children's Hospital. Drive-thru PPVs were also set up at Universiti Teknologi Mara (UiTM) Puncak Alam campus, with more to come at another 19 higher learning institutions.

10/07/2021

How do we know that COVID-19 vaccines are safe?

🧑🏼‍🔬 There are strict protections in place to help ensure the safety of all COVID-19 vaccines. Before receiving validation from WHO and national regulatory agencies, COVID-19 vaccines must undergo rigorous testing in clinical trials to prove that they meet internationally agreed benchmarks for safety and efficacy.

👨🏼‍🔬 Unprecedented scientific collaborations have allowed COVID-19 vaccine research, development, and authorizations to be completed in record time – to meet the urgent need for these vaccines while maintaining high safety standards. As with all vaccines, WHO and regulatory authorities will continuously monitor the use of COVID-19 vaccines to identify and respond to any safety issues that might arise, and through that process to assure they remain safe for use around the world

10/07/2021

MALAYSIA’S DAILY COVID-19 VACCINATION RATE SLIPS TO 217,807 DOSES

Malaysia administered 217,807 doses of Covid-19 vaccine yesterday (July 3), down from 236,196 vaccine doses administered on July 2, according to data from the Covid-19 Vaccine Supply Access Guarantee Special Committee (JKJAV) today.
Of the 217,807 doses given out, 141,140 went to first-dose recipients, while the remainders went to 76,667 second-dose recipients, JKJAV shared via Twitter. The seven-day moving average for Covid-19 vaccination stood at 224,822, compared to 220,546 the day before.
A total of 8.8 million vaccine doses had been administered so far, with 2.54 million Malaysians or 7.8% of the population fully vaccinated, while 3.72 million or 19.2% had received their first jab.

10/07/2021

There are four types of COVID-19 vaccines: here’s how they work :
There are four categories of vaccines in clinical trials: WHOLE VIRUS, PROTEIN SUBUNIT, NUCLEIC ACID (RNA AND DNA) and VIRAL VECTOR. Some of them try to smuggle the antigen into the body, others use the body’s own cells to make the viral antigen.

Whole Virus :-
Many conventional vaccines use whole viruses to trigger an immune response. There are two main approaches. Live attenuated vaccines use a weakened form of the virus that can still replicate without causing illness. Inactivated vaccines use viruses whose genetic material has been destroyed so they cannot replicate, but can still trigger an immune response.

Protein Subunit :-
Subunit vaccines use pieces of the pathogen - often fragments of protein - to trigger an immune response. Doing so minimizes the risk of side effects, but it also means the immune response may be weaker.

Nucleic Acid :-
Nucleic acid vaccines use genetic material – either RNA or DNA – to provide cells with the instructions to make the antigen. In the case of COVID-19, this is usually the viral spike protein. Once this genetic material gets into human cells, it uses our cells' protein factories to make the antigen that will trigger an immune response. The advantages of such vaccines are that they are easy to make, and cheap. Since the antigen is produced inside our own cells and in large quantities, the immune reaction should be strong.

Viral Vector :-
Viral vector vaccines also work by giving cells genetic instructions to produce antigens. But they differ from nucleic acid vaccines in that they use a harmless virus, different from the one the vaccine is targeting, to deliver these instructions into the cell. One type of virus that has often been used as a vector is adenovirus, which causes the common cold. As with nucleic acid vaccines, our own cellular machinery is hijacked to produce the antigen from those instructions, in order to trigger an immune response. Viral vector vaccines can mimic natural viral infection and should therefore trigger a strong immune response

10/07/2021

Variant of Covid-19

✨ Variant B.1.1.7, which first emerged from the United Kingdom, will be known as Alpha.

✨ Variant B.1.351, which was first detected in South Africa last May, will be known as Beta.

✨ Gamma will be used to refer to P.1, the variant first detected in Brazil last November.

✨ Delta will be the new name for B.1.617.2, the poorly nicknamed “double mutant” strain that was first identified in India last October.

10/07/2021

What are the Benefits of Getting the COVID-19 Vaccine?

Although experts are still learning a lot about the COVID-19 vaccines, there are some clear benefits to getting vaccinated.

1. The vaccine reduces your risk of infection.

- Once you receive your first shot, your body begins producing antibodies to the coronavirus. These antibodies help your immune system fight the virus if you happen to be exposed, so it reduces your chance of getting the disease.

2. The vaccine can help your unborn baby or newborn.

- A new study found that expectant mothers who receive the COVID-19 vaccine create antibodies to the virus and pass those to their unborn baby through the placenta. Mothers were also shown to pass antibodies to their newborns through breast milk. This suggests those newborns have some immunity to the virus, which is especially important as young children cannot get the vaccine.

3. The vaccine (eventually) will help us ditch the masks.

- The vaccine is the final step in our effort to get back to a more normal way of life. Public health measures such as mask wearing, physical distancing and hand-washing were implemented to slow the spread of the virus, and they have proven to work. We should continue with these precautions until enough people are immunized, especially the most vulnerable in our community.

10/07/2021

Impacts of COVID-19 in daily life

✨ Healthcare

• Challenges in the diagnosis, quarantine and treatment of suspected or confirmed cases
• High burden of the functioning of the existing medical system
• Patients with other disease and health problems are getting neglected

✨ Economic

• Slowing of the manufacturing of essential goods
• Disrupt the supply chain of products

✨ Social

• Service sector is not being able to provide their proper service
• Cancellation or postponement of large-scale sports and tournaments
• Avoiding the national and international travelling and cancellation of services

10/07/2021

"Malaysia Prihatin Programme to Serve as COVID-19, Vaccination Awareness Campaign Platform"

The Malaysia Prihatin programme will now be one of the main platforms to conduct awareness campaigns about the dangers of COVID-19 and to encourage Malaysians to register themselves for vaccination.

Energy and Natural Resources Minister Datuk Seri Dr Shamsul Anuar Nasarah said the government is intensifying its efforts as the number of individuals who have registered to receive vaccination shots was still too low.

Local media reported previously that registrations on the MySejathera app for vaccinations have slowed down tremendously.

The Special Muzakarah Committee of the National Council for Malaysian Islamic Affairs has decided that the COVID-19 vaccine use is permissible and obligatory for the groups set by the government.

10/07/2021

To prevent the spread of COVID-19:

🥰 Clean your hands often. Use soap and water, or an alcohol-based hand rub.
🥰 Maintain a safe distance from anyone who is coughing or sneezing.
🥰 Wear a mask when physical distancing is not possible.
🥰 Don’t touch your eyes, nose or mouth.
🥰 Cover your nose and mouth with your bent elbow or a tissue when you cough or sneeze.
🥰 Stay home if you feel unwell.
🥰 If you have a fever, cough and difficulty breathing, seek medical attention.

10/07/2021

Vaccines are usually tested in adults first, and only later assessed in children when safety has been proven in adults, because children are still developing and growing. COVID-19 has also been a more serious and dangerous disease among older people. Now that the vaccines have been determined to be safe for adults, they are being studied in children.

WHO's Strategic Advisory Group of Experts (SAGE) has concluded that the Pfizer/BionTech vaccine is suitable for use by people aged 12 years and above. Children aged between 12 and 15 who are at higher risk of severe COVID-19 may be offered this vaccine alongside other priority groups for vaccination. Vaccine trials for children are ongoing and WHO will update its recommendations when the evidence or epidemiological situation justifies a change in policy.

While the supply of vaccines is limited, the ongoing priority is to vaccinate those most at risk of serious illness who still have not been vaccinated in many parts of the world: older people, those with chronic health conditions, and health workers.

Most children are at low risk of serious disease and vaccinating them is primarily about reducing transmission, which can also be achieved through public health measures, including: physically distancing from others, cleaning hands frequently, sneezing and coughing into their elbow, wearing a mask if age appropriate and avoiding crowded, poorly ventilated spaces.

Uitm.Palam33

10/07/2021

10/07/2021

10/07/2021

10/07/2021

10/07/2021

10/07/2021

10/07/2021

10/07/2021

10/07/2021

10/07/2021

10/07/2021

10/07/2021

Address

Website

Alerts

Shortcuts

Share

Category